5.0
19 Feb 2014
Current employee, more than 5 years
South San Francisco, CA
Recommend
CEO approval
Business outlook
Pros
Casual Intensity. Focus on Patients. Following the Science. Genentech is also a member of the Roche Group which gives it a global reach. Exciting to be expanding into China and Latin America.
Cons
At times too functionally siloed. Not convinced having too separate Research and Early Development organizations is economically prudent.